Ulrika Yngve
Forskare vid Institutionen för läkemedelskemi; Preparativ läkemedelskemi
- Telefon:
- 018-471 41 24
- E-post:
- ulrika.yngve@scilifelab.uu.se
- Besöksadress:
- Uppsala Biomedicinska Centrum, BMC, Husarg. 3
- Postadress:
- Box 574
751 23 UPPSALA
- CV:
- Ladda ned CV
Kort presentation
Head of Facility för Medicinal Chemistry, Lead Identification, Drug Discovery and Development Platform, Science for Life Laboratory. Information om plattformen finns på https://www.scilifelab.se/platforms/ddd.
Jag är läkemedelskemist med 12 års erfarenhet av industriell läkemedelsforskning vid AstraZeneca i Södertälje. I vårt arbete vid plattformen samarbetar vi med akademiska forskare för att leverera högkvalitativa föreningar och data i projekt med syfte att ta fram nya läkemedel.

Publikationer
Urval av publikationer
-
Ingår i Journal of Medicinal Chemistry, s. 3915-3934, 2020
- DOI för Optimization of Tetrahydroindazoles as Inhibitors of Human Dihydroorotate Dehydrogenase and Evaluation of Their Activity and In Vitro Metabolic Stability
- Ladda ner fulltext (pdf) av Optimization of Tetrahydroindazoles as Inhibitors of Human Dihydroorotate Dehydrogenase and Evaluation of Their Activity and In Vitro Metabolic Stability
-
Ingår i Nature Communications, 2018
- DOI för A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
- Ladda ner fulltext (pdf) av A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
-
Ingår i Neuropharmacology, s. 293-300, 2017
-
Ingår i MedChemComm, s. 422-431, 2013
-
Ingår i Chemistry and Biodiversity, s. 2442-2452, 2012
Senaste publikationer
-
Ingår i Journal of Medicinal Chemistry, s. 3915-3934, 2020
- DOI för Optimization of Tetrahydroindazoles as Inhibitors of Human Dihydroorotate Dehydrogenase and Evaluation of Their Activity and In Vitro Metabolic Stability
- Ladda ner fulltext (pdf) av Optimization of Tetrahydroindazoles as Inhibitors of Human Dihydroorotate Dehydrogenase and Evaluation of Their Activity and In Vitro Metabolic Stability
-
Ingår i Nature Communications, 2018
- DOI för A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
- Ladda ner fulltext (pdf) av A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
-
Automated GMP-production of α-[11 C]methyl-L-tryptophan using a tracer production system (TPS)
Ingår i Journal of labelled compounds & radiopharmaceuticals, s. 1106-1109, 2018
-
Ingår i Neuropharmacology, s. 293-300, 2017
-
Tracing BACE: Synthesis and evaluation of beta-secretase inhibitors as ligands for PET imaging
Ingår i Journal of labelled compounds & radiopharmaceuticals, 2015
Alla publikationer
Artiklar i tidskrift
-
Ingår i Journal of Medicinal Chemistry, s. 3915-3934, 2020
- DOI för Optimization of Tetrahydroindazoles as Inhibitors of Human Dihydroorotate Dehydrogenase and Evaluation of Their Activity and In Vitro Metabolic Stability
- Ladda ner fulltext (pdf) av Optimization of Tetrahydroindazoles as Inhibitors of Human Dihydroorotate Dehydrogenase and Evaluation of Their Activity and In Vitro Metabolic Stability
-
Ingår i Nature Communications, 2018
- DOI för A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
- Ladda ner fulltext (pdf) av A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
-
Automated GMP-production of α-[11 C]methyl-L-tryptophan using a tracer production system (TPS)
Ingår i Journal of labelled compounds & radiopharmaceuticals, s. 1106-1109, 2018
-
Ingår i Neuropharmacology, s. 293-300, 2017
-
Tracing BACE: Synthesis and evaluation of beta-secretase inhibitors as ligands for PET imaging
Ingår i Journal of labelled compounds & radiopharmaceuticals, 2015
-
Ingår i MedChemComm, s. 422-431, 2013
-
Ingår i Chemistry and Biodiversity, s. 2442-2452, 2012
-
Ingår i Journal of Medicinal Chemistry, s. 6866-6880, 2012
-
Ingår i Nuclear Medicine and Biology, s. 1073-1078, 2004
-
Microwave accelerated 68Ga-labelling of oligonucleotides
Ingår i Journal of Labelled Compounds & Radiopharmaceuticals, s. 79-89, 2004
-
Labelling of octreotide using Br-76-prosthetic groups
Ingår i Journal of labelled compounds & radiopharmaceuticals, s. 561-573, 2001
-
Ingår i European Journal of Pharmaceutical Sciences, s. 179-186, 2000
-
Ingår i Nuclear Medicine and Biology, s. 851-853, 2000
-
Ingår i Acta Chemica Scandinavica, s. 508-512, 1999
-
Ingår i Acta Chemica Scandinavica, s. 651-669, 1999
Konferensbidrag
-
Tritium labeling of a class of spirooxazaindolamines possessing analgesic properties.
Ingår i Synth. Appl. Isot. Labelled Compd., Proc. Int. Symp., 8th, s. 285-288, 2004
-
Ingår i Synth. Appl. Isot. Labelled Compd. 1997, Proc. Int. Symp., 6th, s. 303-305, 1998
Patent
-
2014
-
2014
-
2014
-
2011
-
Preparation of imidazolyl-pyrimidine derivatives as GSK3 inhibitors.
2008
-
Preparation of arylimidazopyridine derivatives for use as GSK3 modulators.
2008
-
Preparation of imidazopyridinecarboxamide derivatives for use as GSK3 modulators.
2008
-
Preparation of piperazinyl quinazolines as 5-HT6 modulators.
2007
-
Preparation of piperazinyl quinazolines as 5-HT6 modulators.
2007
-
2006
-
Preparation of five-membered heterocyclic compounds as mGluR5 receptor antagonists.
2004